Jonathan J. Paly

1.4k total citations
49 papers, 977 citations indexed

About

Jonathan J. Paly is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Radiation. According to data from OpenAlex, Jonathan J. Paly has authored 49 papers receiving a total of 977 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Pulmonary and Respiratory Medicine, 19 papers in Surgery and 9 papers in Radiation. Recurrent topics in Jonathan J. Paly's work include Prostate Cancer Diagnosis and Treatment (18 papers), Prostate Cancer Treatment and Research (15 papers) and Bladder and Urothelial Cancer Treatments (10 papers). Jonathan J. Paly is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (18 papers), Prostate Cancer Treatment and Research (15 papers) and Bladder and Urothelial Cancer Treatments (10 papers). Jonathan J. Paly collaborates with scholars based in United States, Canada and Austria. Jonathan J. Paly's co-authors include Jason A. Efstathiou, Anthony L. Zietman, William U. Shipley, Andrzej Niemierko, John J. Coen, Niall M. Heney, Donald S. Kaufman, Francis J. McGovern, Daphna Y. Spiegel and Ayal A. Aizer and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and The Journal of Urology.

In The Last Decade

Jonathan J. Paly

42 papers receiving 946 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonathan J. Paly United States 17 532 426 222 196 155 49 977
Giario Conti Italy 17 430 0.8× 893 2.1× 176 0.8× 179 0.9× 50 0.3× 39 1.3k
L. Cormier France 21 406 0.8× 822 1.9× 142 0.6× 241 1.2× 95 0.6× 90 1.3k
Holger Borchers Germany 20 211 0.4× 681 1.6× 125 0.6× 150 0.8× 180 1.2× 58 930
Göran Borghede Sweden 13 360 0.7× 408 1.0× 108 0.5× 322 1.6× 139 0.9× 18 857
Daniel Taussky Canada 19 325 0.6× 860 2.0× 113 0.5× 228 1.2× 460 3.0× 133 1.3k
Venu Chalasani Australia 17 422 0.8× 734 1.7× 321 1.4× 164 0.8× 48 0.3× 73 1.3k
Robert G. Ferrigni United States 24 430 0.8× 1.1k 2.6× 212 1.0× 148 0.8× 251 1.6× 56 1.4k
A. Hervás Spain 14 204 0.4× 503 1.2× 52 0.2× 263 1.3× 146 0.9× 54 807
Ryan K. Berglund United States 19 464 0.9× 961 2.3× 193 0.9× 147 0.8× 44 0.3× 59 1.3k
Jason Hafron United States 22 348 0.7× 863 2.0× 265 1.2× 181 0.9× 30 0.2× 117 1.3k

Countries citing papers authored by Jonathan J. Paly

Since Specialization
Citations

This map shows the geographic impact of Jonathan J. Paly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan J. Paly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan J. Paly more than expected).

Fields of papers citing papers by Jonathan J. Paly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan J. Paly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan J. Paly. The network helps show where Jonathan J. Paly may publish in the future.

Co-authorship network of co-authors of Jonathan J. Paly

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan J. Paly. A scholar is included among the top collaborators of Jonathan J. Paly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan J. Paly. Jonathan J. Paly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bonora, Giancarlo, et al.. (2026). Prognostic Value of Tumor-Informed Circulating Tumor DNA in HPV–Independent Head and Neck Squamous Cell Carcinoma. JAMA Otolaryngology–Head & Neck Surgery. 152(3). 249–249.
2.
Paly, Jonathan J., et al.. (2024). Developing an educational “hub”: impact of a distance-learning curriculum in a multinational cohort. BMC Medical Education. 24(1). 406–406. 1 indexed citations
3.
Deng, Mengying, Elizabeth Handorf, Jonathan J. Paly, et al.. (2021). Early Prostate-Specific Antigen Kinetics for Low- and Intermediate-Risk Prostate Cancer Treated With Definitive Radiation Therapy. Practical Radiation Oncology. 12(1). 60–67.
4.
Vapiwala, Neha, J.K. Wong, Elizabeth A. Handorf, et al.. (2021). A Pooled Toxicity Analysis of Moderately Hypofractionated Proton Beam Therapy and Intensity Modulated Radiation Therapy in Early-Stage Prostate Cancer Patients. International Journal of Radiation Oncology*Biology*Physics. 110(4). 1082–1089. 15 indexed citations
5.
Wong, J.K., Neha Vapiwala, Elizabeth A. Handorf, et al.. (2020). A Multi-institutional, Propensity Score-Weighted Comparison of Moderately Hypofractionated Photon and Proton Therapy for 1850 Patients with Low or Intermediate Risk Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 108(3). e884–e884. 1 indexed citations
6.
Paly, Jonathan J., Chun Chieh Lin, Phillip J. Gray, et al.. (2016). Management and outcomes of clinical stage IIA/B seminoma: Results from the National Cancer Data Base 1998-2012. Practical Radiation Oncology. 6(6). e249–e258. 14 indexed citations
7.
Preston, Mark A., Adam S. Feldman, John J. Coen, et al.. (2015). Active surveillance for low-risk prostate cancer: Need for intervention and survival at 10 years. Urologic Oncology Seminars and Original Investigations. 33(9). 383.e9–383.e16. 22 indexed citations
8.
Paly, Jonathan J., Christopher L. Hallemeier, Peter J. Biggs, et al.. (2014). Outcomes in a Multi-institutional Cohort of Patients Treated With Intraoperative Radiation Therapy for Advanced or Recurrent Renal Cell Carcinoma. International Journal of Radiation Oncology*Biology*Physics. 88(3). 618–623. 25 indexed citations
9.
Gray, Phillip J., Jonathan J. Paly, Beow Y. Yeap, et al.. (2013). Patient‐reported outcomes after 3‐dimensional conformal, intensity‐modulated, or proton beam radiotherapy for localized prostate cancer. Cancer. 119(9). 1729–1735. 72 indexed citations
10.
Paly, Jonathan J., Jason A. Efstathiou, Sandeep Hedgire, et al.. (2013). Mapping patterns of nodal metastases in seminoma: Rethinking radiotherapy fields. Radiotherapy and Oncology. 106(1). 64–68. 12 indexed citations
11.
Aizer, Ayal A., Jonathan J. Paly, & Jason A. Efstathiou. (2013). Multidisciplinary Care and Management Selection in Prostate Cancer. Seminars in Radiation Oncology. 23(3). 157–164. 22 indexed citations
12.
Efstathiou, Jason A., Jonathan J. Paly, Hsiao‐Ming Lu, et al.. (2012). Adjuvant radiation therapy for early stage seminoma: Proton versus photon planning comparison and modeling of second cancer risk. Radiotherapy and Oncology. 103(1). 12–17. 28 indexed citations
13.
Gray, Phillip J., Jonathan J. Paly, Martin G. Sanda, et al.. (2012). Bowel and bladder toxicity patterns in patients with prostate cancer treated with proton beam versus intensity-modulated radiation therapy.. Journal of Clinical Oncology. 30(5_suppl). 22–22. 1 indexed citations
14.
Shah, Anand, Jonathan J. Paly, Jason A. Efstathiou, & Justin E. Bekelman. (2012). Physician Evaluation of Internet Health Information on Proton Therapy for Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 85(4). e173–e177. 16 indexed citations
15.
Aizer, Ayal A., Jonathan J. Paly, Anthony L. Zietman, et al.. (2012). Multidisciplinary care and pursuit of active surveillance in low-risk prostate cancer.. Journal of Clinical Oncology. 30(5_suppl). 131–131. 5 indexed citations
16.
Shah, Anand, Jason A. Efstathiou, Jonathan J. Paly, et al.. (2012). Prospective Preference Assessment of Patients' Willingness to Participate in a Randomized Controlled Trial of Intensity-Modulated Radiotherapy Versus Proton Therapy for Localized Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 83(1). e13–e19. 33 indexed citations
17.
Eswara, Jairam R., Jason A. Efstathiou, Niall M. Heney, et al.. (2012). 1414 COMPLICATIONS AND LONG-TERM RESULTS OF SALVAGE CYSTECTOMY AFTER FAILED BLADDER-SPARING THERAPY FOR MUSCLE-INVASIVE BLADDER CANCER. The Journal of Urology. 187(4S). 6 indexed citations
18.
Efstathiou, Jason A., Daphna Y. Spiegel, William U. Shipley, et al.. (2011). Long-Term Outcomes of Selective Bladder Preservation by Combined-Modality Therapy for Invasive Bladder Cancer: The MGH Experience. European Urology. 61(4). 705–711. 293 indexed citations
19.
Coen, John J., Jonathan J. Paly, Andrzej Niemierko, et al.. (2011). Long-Term Quality of Life Outcome After Proton Beam Monotherapy for Localized Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 82(2). e201–e209. 26 indexed citations
20.
Tang, Shikui, Stefan Both, Jonathan J. Paly, et al.. (2011). Improvement of Prostate Treatment by Anterior Proton Fields. International Journal of Radiation Oncology*Biology*Physics. 83(1). 408–418. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026